Flex Pharma IPO Info
Company Name: Flex Pharma
Stock Symbol: FLKS
Exchange: NASDAQ
Status: Priced
IPO Date: 1/29/2015
IPO Price:
16.00 (
-22.19%)
Underwriters
Jefferies and Piper Jaffray
Amount of Offering: N/A
Number of Shares Offered: 5.4 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
Flex Pharma is a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps and spasms associated with severe neuromuscular conditions. Novel insights regarding neuromuscular physiology from our co-founders form the basis of the company's development efforts. Flex Pharma believes that activation of certain receptors in primary sensory neurons reduces the repetitive firing, or hyperexcitability, of alpha-motor neurons, thereby preventing or reducing the frequency and intensity of muscle cramps and spasms. They also believe that they are the only company developing products based on this mechanism of muscle cramp and spasm inhibition. The company has conducted three randomized, blinded, placebo-controlled cross-over studies of our proprietary treatment, which have shown a statistically significant reduction in the intensity of muscle cramps induced in healthy normal volunteers. The company intends to initially focus their drug development efforts on developing a product to treat nocturnal leg cramps. There is no drug product currently available in the United States that has been approved to treat nocturnal leg cramps.
SEC Filings
News Headlines
